Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

NCT04696939 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Small-cell Lung Cancer
Neoadjuvant Therapy

Interventions

DRUG: Atezolizumab
DRUG: Carboplatin
DRUG: Etoposide

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China